Intravascular
(IV) catheters are essential devices in the hospital
that are used to monitor a patient’s blood and for administering
drugs or nutrients. However, IV catheters are also prone to blood
clotting at the point of insertion and infection by formation of robust
bacterial biofilms on their surface. Nitric oxide (NO) is ideally
suited to counteract both of these problems, due to its ability to
inhibit platelet activation/aggregation and its antimicrobial properties.
One way to equip catheters with NO releasing properties is by electrocatalytic
nitrite reduction to NO by copper complexes in a multilumen configuration.
In this work, we systematically investigate six closely related Cu(II)
BMPA- and BEPA-carboxylate complexes (BMPA = bis(2-methylpyridyl)amine);
BEPA = bis(2-ethylpyridyl)amine), using carboxylate groups of different
chain lengths. The corresponding Cu(II) complexes were characterized
using UV–vis, EPR spectroscopy, and X-ray crystallography.
Using detailed cyclic voltammetry (CV) and bulk electrocatalyic studies
(with real-time NO quantification), in aqueous media, pH 7.4, we are
able to derive clear reactivity relations between the ligand structures
of the complexes, their Faradaic efficiencies for NO generation, their
turnover frequencies (TOFs), and their redox potentials. Our results
show that the complex [Cu(BEPA-Bu)](OAc) is the best catalyst with
a high Faradaic efficiency over large nitrite concentration ranges
and the expected best tolerance to oxygen levels. For this species,
the more positive reduction potential suppresses NO disproportionation,
which is a major Achilles heel of the (faster) catalysts with the
more negative reduction potentials.